Understanding how Botulinum Neurotoxins work and their effectiveness
Characteristics of Botulinum Neurotoxins the Determine Potency
This study is looking into how certain powerful toxins work in the body, with the goal of improving treatments for muscle-related conditions, so patients can have better options for their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10980625 on NIH RePORTER |
What this research studies
This research investigates the characteristics of Botulinum Neurotoxins (BoNTs), which are potent toxins that can cause severe illness in humans and animals. The study focuses on understanding the mechanisms that contribute to the potency and long-lasting effects of these toxins, particularly the subtypes used in medical treatments. By examining the interactions of these toxins at the cellular level, the research aims to improve therapeutic applications for various neuromuscular disorders. Patients may benefit from enhanced treatments derived from a better understanding of BoNTs.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with specific neuromuscular disorders that are currently treated with Botulinum Neurotoxins.
Not a fit: Patients who do not have neuromuscular disorders or those who are not candidates for Botulinum Neurotoxin treatments may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapeutic options for patients suffering from neuromuscular disorders.
How similar studies have performed: Previous research has shown success in understanding the mechanisms of Botulinum Neurotoxins, but this specific investigation into potency and duration of action is novel.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Pellett, Sabine — University of Wisconsin-Madison
- Study coordinator: Pellett, Sabine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.